• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

mTOR:在代谢性疾病、癌症和衰老过程中的关键作用。

mTOR: Its Critical Role in Metabolic Diseases, Cancer, and the Aging Process.

机构信息

Biochemistry and Molecular Biology Department, Dasman Diabetes Institute, P.O. Box 1180, Dasman 15462, Kuwait.

Department of Translational Research, Dasman Diabetes Institute, P.O. Box 1180, Dasman 15462, Kuwait.

出版信息

Int J Mol Sci. 2024 Jun 2;25(11):6141. doi: 10.3390/ijms25116141.

DOI:10.3390/ijms25116141
PMID:38892329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11173325/
Abstract

The mammalian target of rapamycin (mTOR) is a pivotal regulator, integrating diverse environmental signals to control fundamental cellular functions, such as protein synthesis, cell growth, survival, and apoptosis. Embedded in a complex network of signaling pathways, mTOR dysregulation is implicated in the onset and progression of a range of human diseases, including metabolic disorders such as diabetes and cardiovascular diseases, as well as various cancers. mTOR also has a notable role in aging. Given its extensive biological impact, mTOR signaling is a prime therapeutic target for addressing these complex conditions. The development of mTOR inhibitors has proven advantageous in numerous research domains. This review delves into the significance of mTOR signaling, highlighting the critical components of this intricate network that contribute to disease. Additionally, it addresses the latest findings on mTOR inhibitors and their clinical implications. The review also emphasizes the importance of developing more effective next-generation mTOR inhibitors with dual functions to efficiently target the mTOR pathways. A comprehensive understanding of mTOR signaling will enable the development of effective therapeutic strategies for managing diseases associated with mTOR dysregulation.

摘要

哺乳动物雷帕霉素靶蛋白(mTOR)是一个关键的调节剂,整合了多种环境信号来控制基本的细胞功能,如蛋白质合成、细胞生长、存活和凋亡。mTOR 失调嵌入在复杂的信号通路网络中,与多种人类疾病的发生和进展有关,包括代谢紊乱如糖尿病和心血管疾病以及各种癌症。mTOR 在衰老中也有显著作用。鉴于其广泛的生物学影响,mTOR 信号是解决这些复杂情况的主要治疗靶点。mTOR 抑制剂的开发已在许多研究领域证明是有利的。这篇综述深入探讨了 mTOR 信号的意义,强调了这个复杂网络中对疾病有贡献的关键组成部分。此外,它还讨论了最新的 mTOR 抑制剂发现及其临床意义。该综述还强调了开发具有双重功能的更有效的下一代 mTOR 抑制剂来有效靶向 mTOR 途径的重要性。对 mTOR 信号的全面理解将能够为管理与 mTOR 失调相关的疾病制定有效的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d3c/11173325/fd36478b8daa/ijms-25-06141-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d3c/11173325/fc988377e686/ijms-25-06141-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d3c/11173325/455713df0f5b/ijms-25-06141-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d3c/11173325/308c9cf4cb12/ijms-25-06141-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d3c/11173325/fd36478b8daa/ijms-25-06141-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d3c/11173325/fc988377e686/ijms-25-06141-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d3c/11173325/455713df0f5b/ijms-25-06141-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d3c/11173325/308c9cf4cb12/ijms-25-06141-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d3c/11173325/fd36478b8daa/ijms-25-06141-g004.jpg

相似文献

1
mTOR: Its Critical Role in Metabolic Diseases, Cancer, and the Aging Process.mTOR:在代谢性疾病、癌症和衰老过程中的关键作用。
Int J Mol Sci. 2024 Jun 2;25(11):6141. doi: 10.3390/ijms25116141.
2
mTOR Signaling in Growth, Metabolism, and Disease.生长、代谢及疾病中的mTOR信号传导
Cell. 2017 Mar 9;168(6):960-976. doi: 10.1016/j.cell.2017.02.004.
3
Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy.靶向多发性骨髓瘤中的 mTOR 信号通路:生物学及治疗意义。
Cell Commun Signal. 2024 Jun 11;22(1):320. doi: 10.1186/s12964-024-01699-3.
4
The complex network of mTOR signalling in the heart.心脏中 mTOR 信号的复杂网络。
Cardiovasc Res. 2022 Jan 29;118(2):424-439. doi: 10.1093/cvr/cvab033.
5
The Roles of Post-Translational Modifications on mTOR Signaling.翻译:翻译后修饰在 mTOR 信号通路中的作用。
Int J Mol Sci. 2021 Feb 11;22(4):1784. doi: 10.3390/ijms22041784.
6
Rapamycin: one drug, many effects.雷帕霉素:一种药物,多种效应。
Cell Metab. 2014 Mar 4;19(3):373-9. doi: 10.1016/j.cmet.2014.01.001. Epub 2014 Feb 6.
7
The Cytoprotective and Cytotoxic Functions of Autophagy in Response to mTOR Inhibitors.自噬在响应mTOR抑制剂时的细胞保护和细胞毒性功能
Front Biosci (Landmark Ed). 2024 Jun 24;29(6):231. doi: 10.31083/j.fbl2906231.
8
Inhibitors of the mTOR signaling pathway can play an important role in breast cancer immunopathogenesis.mTOR 信号通路抑制剂在乳腺癌免疫发病机制中可以发挥重要作用。
Cell Biol Int. 2024 Nov;48(11):1601-1611. doi: 10.1002/cbin.12231. Epub 2024 Aug 20.
9
Polyploidy and mTOR signaling: a possible molecular link.多倍体和 mTOR 信号:一个可能的分子联系。
Cell Commun Signal. 2024 Mar 27;22(1):196. doi: 10.1186/s12964-024-01526-9.
10
Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin.雷帕霉素之后的新治疗时代:靶向抑制 Rictor/mTORC2 治疗癌症。
Curr Cancer Drug Targets. 2016;16(4):288-304. doi: 10.2174/1568009616666151113120830.

引用本文的文献

1
Lignin-Derived Oligomers as Promising mTOR Inhibitors: Insights from Dynamics Simulations.木质素衍生的低聚物作为有前景的mTOR抑制剂:动力学模拟的见解
Int J Mol Sci. 2025 Sep 7;26(17):8728. doi: 10.3390/ijms26178728.
2
AMPK Signaling Regulates Epithelioid Hemangioendothelioma Cell Growth.AMPK信号传导调节上皮样血管内皮瘤细胞的生长。
Cancers (Basel). 2025 Sep 2;17(17):2889. doi: 10.3390/cancers17172889.
3
ORMDL2 Promotes the Growth of Glioma through mTORC1-Mediated Fatty Acid Metabolism.ORMDL2通过mTORC1介导的脂肪酸代谢促进胶质瘤生长。

本文引用的文献

1
Taurine Inhibits Lung Metastasis in Triple-Negative Breast Cancer by Modulating Macrophage Polarization Through PTEN-PI3K/Akt/mTOR Pathway.牛磺酸通过 PTEN-PI3K/Akt/mTOR 通路调节巨噬细胞极化抑制三阴性乳腺癌肺转移。
J Immunother. 2024;47(9):369-377. doi: 10.1097/CJI.0000000000000518. Epub 2024 Apr 17.
2
PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer.PI3K/AKT/mTOR 信号通路:三阴性乳腺癌的重要驱动因子和治疗靶点。
Breast Cancer. 2024 Jul;31(4):539-551. doi: 10.1007/s12282-024-01567-5. Epub 2024 Apr 17.
3
A Free Amino Acid Diet Alleviates Colorectal Tumorigenesis through Modulating Gut Microbiota and Metabolites.
Appl Biochem Biotechnol. 2025 Sep 2. doi: 10.1007/s12010-025-05362-6.
4
Immunosenescence: signaling pathways, diseases and therapeutic targets.免疫衰老:信号通路、疾病与治疗靶点。
Signal Transduct Target Ther. 2025 Aug 6;10(1):250. doi: 10.1038/s41392-025-02371-z.
5
Post-translational modifications orchestrate mTOR-driven cell death in cardiovascular disease.翻译后修饰调控心血管疾病中mTOR驱动的细胞死亡。
Front Cardiovasc Med. 2025 Jul 15;12:1620669. doi: 10.3389/fcvm.2025.1620669. eCollection 2025.
6
Current Insights of the Potential Plant Bioactive Compounds on Modulating the mTOR Signaling Pathway in Regulating Oncological Disorders.植物生物活性化合物在调节mTOR信号通路以调控肿瘤疾病方面的潜在作用的当前见解
Phytother Res. 2025 Sep;39(9):4046-4059. doi: 10.1002/ptr.70051. Epub 2025 Jul 27.
7
Exploring Potential Therapeutic Applications of Tazarotene: Gene Regulation Mechanisms and Effects on Melanoma Cell Growth.探索他扎罗汀的潜在治疗应用:基因调控机制及其对黑色素瘤细胞生长的影响
Curr Issues Mol Biol. 2025 Mar 28;47(4):237. doi: 10.3390/cimb47040237.
8
Branched-chain amino acid and cancer: metabolism, immune microenvironment and therapeutic targets.支链氨基酸与癌症:代谢、免疫微环境及治疗靶点
J Transl Med. 2025 Jun 10;23(1):636. doi: 10.1186/s12967-025-06664-3.
9
Early menopause in mothers and the risks of pre-diabetes and type 2 diabetes mellitus in female and male offspring: a population-based cohort study.母亲早绝经与子代患糖尿病前期及2型糖尿病的风险:一项基于人群的队列研究
Reprod Biol Endocrinol. 2025 May 22;23(1):76. doi: 10.1186/s12958-025-01405-z.
10
Virtual screening and molecular dynamics simulation study of ATP-competitive inhibitors targeting mTOR protein.靶向mTOR蛋白的ATP竞争性抑制剂的虚拟筛选与分子动力学模拟研究
PLoS One. 2025 May 5;20(5):e0319608. doi: 10.1371/journal.pone.0319608. eCollection 2025.
一种游离氨基酸饮食通过调节肠道微生物群和代谢物来减轻结直肠肿瘤的发生。
Nutrients. 2024 Apr 3;16(7):1040. doi: 10.3390/nu16071040.
4
The role of the immunosuppressive PD-1/PD-L1 checkpoint pathway in the aging process and age-related diseases.免疫抑制性 PD-1/PD-L1 检查点通路在衰老过程和与年龄相关疾病中的作用。
J Mol Med (Berl). 2024 Jun;102(6):733-750. doi: 10.1007/s00109-024-02444-6. Epub 2024 Apr 11.
5
The prognosis of patients treated with everolimus for advanced ER-positive, HER2-negative breast cancer is driven by molecular features.接受依维莫司治疗的晚期 ER 阳性、HER2 阴性乳腺癌患者的预后受分子特征的影响。
J Pathol Clin Res. 2024 May;10(3):e12372. doi: 10.1002/2056-4538.12372.
6
Belzutifan versus Everolimus in Advanced Kidney Cancer: A Commentary on LITESPARK-005 Trial from ESMO 2023.贝佐替凡与依维莫司治疗晚期肾癌:对2023年欧洲肿瘤内科学会(ESMO)LITESPARK - 005试验的评论
Kidney Cancer. 2024 Feb 8;8(1):23-24. doi: 10.3233/KCA-230024. eCollection 2024.
7
Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.Sapanisertib(CB-228/TAK-228/MLN0128)联合 Ziv-aflibercept 治疗晚期实体瘤患者的 I 期研究。
Cancer Med. 2024 Feb;13(3):e6877. doi: 10.1002/cam4.6877.
8
Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma.影像学作为早期生物标志物预测依维莫司治疗进展性 NF2 相关前庭神经鞘瘤的敏感性。
J Neurooncol. 2024 Apr;167(2):339-348. doi: 10.1007/s11060-024-04596-4. Epub 2024 Feb 19.
9
Virtual docking screening and quantitative structure-activity relationship studies to explore AKT and PI3K inhibitors acting on mTOR in cancers by theoretical biology and medical modeling.通过理论生物学和医学建模进行虚拟对接筛选和定量构效关系研究,以探索作用于癌症中mTOR的AKT和PI3K抑制剂。
Contemp Oncol (Pozn). 2023;27(3):155-162. doi: 10.5114/wo.2023.133709. Epub 2023 Dec 13.
10
Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.mTORC1/2 抑制剂 Sapanisertib(CB-228/TAK-228)联合二甲双胍治疗 mTOR/AKT/PI3K 通路改变的晚期实体恶性肿瘤患者的 I 期研究。
Cancer Res Commun. 2024 Feb 12;4(2):378-387. doi: 10.1158/2767-9764.CRC-22-0260.